Healthcare · Medical Devices
Profusa, Inc.
PFSANASDAQ$0.32−$0.02 (−6.53%)Market closed
| Date | Form | Description | Link |
|---|---|---|---|
| 2026-11-13 | 10-Q | QUARTERLY REPORT | 🔗 |
| 2026-11-10 | PRE 14A | PROXY STATEMENT | 🔗 |
| 2026-11-06 | 8-K | CURRENT REPORTMaterial AgreementOff-Balance SheetFinancial Statements/Exhibits | 🔗 |
| 2026-10-27 | SCHEDULE 13G/A | SCHEDULE 13G/A | 🔗 |
| 2026-10-15 | 8-K | CURRENT REPORTMaterial AgreementOff-Balance SheetUnregistered SalesFinancial Statements/Exhibits | 🔗 |
| 2026-10-09 | 8-K | CURRENT REPORTAuditor ChangeFinancial Statements/Exhibits | 🔗 |
| 2026-10-05 | 8-K | CURRENT REPORTMaterial AgreementOff-Balance SheetFinancial Statements/Exhibits | 🔗 |
| 2026-09-21 | 8-K | CURRENT REPORTShareholder Vote | 🔗 |
| 2026-09-16 | 8-K | CURRENT REPORTMaterial AgreementOff-Balance SheetFinancial Statements/Exhibits | 🔗 |
| 2026-09-15 | 8-K | CURRENT REPORTOther EventsFinancial Statements/Exhibits | 🔗 |
| 2026-09-04 | 4 | Insider Transaction | 🔗 |
| 2026-09-04 | 4 | Insider Transaction | 🔗 |
| 2026-09-01 | 8-K | CURRENT REPORTMaterial AgreementOff-Balance SheetFinancial Statements/Exhibits | 🔗 |
| 2026-08-31 | 8-K | CURRENT REPORTDelistingFinancial Statements/Exhibits | 🔗 |
| 2026-08-28 | DEF 14A | PROXY STATEMENT | 🔗 |
| 2026-08-21 | 8-K | CURRENT REPORTMaterial AgreementOff-Balance SheetUnregistered SalesFinancial Statements/Exhibits | 🔗 |
| 2026-08-20 | 8-K | CURRENT REPORTEarnings ResultsFinancial Statements/Exhibits | 🔗 |
| 2026-08-19 | 4 | Insider Transaction | 🔗 |
| 2026-08-19 | SCHEDULE 13D | SCHEDULE 13D | 🔗 |
| 2026-08-19 | 4 | Insider Transaction | 🔗 |
| 2026-08-19 | 10-Q | QUARTERLY REPORT | 🔗 |
| 2026-08-19 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-08-18 | PRE 14A | PROXY STATEMENT | 🔗 |
| 2026-08-18 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-08-14 | NT 10-Q | NOTIFICATION OF LATE FILING | 🔗 |
| 2026-08-14 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-08-14 | 8-K | CURRENT REPORTMaterial Modification of RightsCharter AmendmentOther EventsFinancial Statements/Exhibits | 🔗 |
| 2026-08-12 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-08-10 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-08-05 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-08-04 | SCHEDULE 13G/A | SCHEDULE 13G/A | 🔗 |
| 2026-08-03 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-07-31 | 8-K | CURRENT REPORTMaterial AgreementUnregistered SalesCharter AmendmentRegulation FD DisclosureOther EventsFinancial Statements/Exhibits | 🔗 |
| 2026-07-30 | 4 | PRIMARY DOCUMENT | 🔗 |
| 2026-07-30 | 3 | PRIMARY DOCUMENT | 🔗 |
| 2026-07-27 | 8-K | CURRENT REPORTExecutive ChangeRegulation FD DisclosureOther EventsFinancial Statements/Exhibits | 🔗 |
| 2026-07-07 | 424B3 | PROSPECTUS SUPPLEMENT | 🔗 |
| 2026-07-07 | 424B3 | PROSPECTUS SUPPLEMENT | 🔗 |
| 2026-07-07 | 424B3 | PROSPECTUS SUPPLEMENT | 🔗 |
| 2026-07-07 | 424B3 | PROSPECTUS SUPPLEMENT | 🔗 |
| 2026-07-07 | 424B3 | PROSPECTUS SUPPLEMENT | 🔗 |
| 2026-07-06 | 8-K | CURRENT REPORTMaterial Modification of RightsCharter AmendmentOther EventsFinancial Statements/Exhibits | 🔗 |
| 2026-06-23 | 8-K | CURRENT REPORTShareholder Vote | 🔗 |
| 2026-06-08 | 424B3 | PROSPECTUS SUPPLEMENT | 🔗 |
| 2026-06-08 | 8-K | CURRENT REPORTOther Events | 🔗 |
| 2026-06-05 | SCHEDULE 13G/A | SCHEDULE 13G/A | 🔗 |
| 2026-05-26 | ARS | ARS | 🔗 |
| 2026-05-26 | DEF 14A | PROXY STATEMENT | 🔗 |
| 2026-05-26 | 8-K | CURRENT REPORTMaterial AgreementFinancial Statements/Exhibits | 🔗 |
| 2026-05-19 | 424B3 | PROSPECTUS SUPPLEMENT | 🔗 |
SEC EDGAR (U.S. Securities and Exchange Commission)